As miR-122 has [[tumour]] protective properties in liver cells,<ref name="Kutay" /><ref name="Coulouarn" /> concerns about a possible risk of [[hepatic cancer]] have been voiced.<ref name="Zsilavecz" /> The drug did not induce liver toxicity in non-human primates,<ref name="pmid18368051" /> nor in a human study.<ref name="van der Ree" />

 

